NeuPT Technologies and VINSI.AI Launch ReadyOS for Physiological Readiness Assessment
NeuPT Technologies and VINSI.AI announced in a press release the launch of ReadyOS, described as a readiness based care platform designed to provide objective physiological readiness assessments before each treatment session.
The system evaluates heart rate variability and autonomic nervous system data in under 90 seconds to generate an actionable recommendation: Train, Adjust, or Protect. This approach aims to replace subjective patient input with measurable physiological information.
ReadyOS integrates clinical domain science from NeuPT Technologies with the AI and cloud engineering capabilities of VINSI.AI. The platform includes a native app for iOS and Android, a clinician web portal, AI assisted reporting with audit trails, and HIPAA compliant infrastructure running on Microsoft Azure.
According to the companies, ReadyOS is built to operate at scale across tens of thousands of devices and is designed for future use in rehabilitation, wellness, and other healthcare segments beyond physical therapy.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidenceLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
TRI Launches TRIAL.OS for Clinical Trial Management
Proprioceptive AI Details Model Interpretability Roadmap
Suvoda Updates Clinical Trial Platform With AI and Unified Access
SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Daily AI Brief: the AI news that matters, in your inbox.